FMP
ANIP icon

Financial Management Professionals’s ANI Pharmaceuticals ANIP Stock Holding History

Financial Management Professionals’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.4K Hold
247
– – ﹤0.01% 447
2026
Q1 		$19K Hold
247
– – ﹤0.01% 418
2025
Q4 		$19.5K Hold
247
– – ﹤0.01% 417
2025
Q3 		$22.6K Buy
+247
New +$20.1K ﹤0.01% 382

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Management Professionals's ANIP Position: Q2 2026 in Review

Financial Management Professionals held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 247 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

Financial Management Professionals first reported a position in ANIP in Q3 2025 and has held it in 4 quarters since. The position peaked at $22.6K in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Financial Management Professionals held 247 shares of ANI Pharmaceuticals worth $20.4K as of Q2 2026.
  • Financial Management Professionals left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Financial Management Professionals's portfolio in Q2 2026, its #447 holding.
  • Financial Management Professionals first reported a position in ANI Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Financial Management Professionals's ANI Pharmaceuticals position peaked at $22.6K in Q3 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Financial Management Professionals's 13F filing for Q2 2026, filed 9 Jul 2026.